Page last updated: 2024-09-05

sb 203580 and bupivacaine

sb 203580 has been researched along with bupivacaine in 2 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (bupivacaine)	Trials (bupivacaine)	Recent Studies (post-2010) (bupivacaine)
3,489	4	1,137	12,968	4,843	3,530

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colvin, HP; Gerner, P; Haller, I; Klimaschewski, L; Lang, L; Lirk, P; Tomaselli, B	1
Lei, HY; Lu, J; Xu, R; Xu, SY; Zhang, QG	1

Other Studies

2 other study(ies) available for sb 203580 and bupivacaine

Article	Year
In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesthesia and analgesia, 2008, Volume: 106, Issue:5 Topics: Amides; Anesthetics, Local; Animals; Anthracenes; Bupivacaine; Butadienes; Cell Size; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Ganglia, Spinal; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lidocaine; Membrane Potentials; Mitogen-Activated Protein Kinases; Neurons, Afferent; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Ropivacaine; Sodium Channels	2008
Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways. European journal of pharmacology, 2011, Apr-25, Volume: 657, Issue:1-3 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anesthetics, Local; Animals; Apoptosis; Bisbenzimidazole; Bupivacaine; Cell Line; Chlorides; Gene Expression Regulation, Enzymologic; Imidazoles; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Pyridines; Reactive Oxygen Species	2011

Article

Year

In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.

Anesthesia and analgesia, 2008, Volume: 106, Issue:5

Topics: Amides; Anesthetics, Local; Animals; Anthracenes; Bupivacaine; Butadienes; Cell Size; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Ganglia, Spinal; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lidocaine; Membrane Potentials; Mitogen-Activated Protein Kinases; Neurons, Afferent; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Ropivacaine; Sodium Channels

2008

Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways.

European journal of pharmacology, 2011, Apr-25, Volume: 657, Issue:1-3

Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anesthetics, Local; Animals; Apoptosis; Bisbenzimidazole; Bupivacaine; Cell Line; Chlorides; Gene Expression Regulation, Enzymologic; Imidazoles; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Pyridines; Reactive Oxygen Species

2011